Surat Institute of Digestive Sciences Hospitals

Surat, Gujarat 395002

3 studies enrolling now · 6 studies all time

What they study most

Gastroparesis, Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis, Obesity, Obstructive Sleep Apnea, Osteoarthritis, Knee, Overweight

Studies at this site

• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis — Recruiting now
• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight — Completed
• Diabetic Gastroparesis Study 05 — Stopped early